NCT02758132 2019-11-08Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone MetastasesUniversity of HawaiiPhase 2 Terminated1 enrolled 7 charts